China's inhalable COVID vaccine may boost antibodies 300-fold
The study suggests a heterologous (mix-match vaccine regimen) prime-boost regimen to increase the breadth, intensity and duration of the immune response, more than a homogeneous (same vaccine regimen) booster shot,
Oct 19, 2021, 10:12 AM IST